Morten Karlsen

St. Olavs Hospital
Trondheim, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Rapid 64Cu radiolabeling and in vivo evaluation of DSPE-NODAGA liposomes in a murine mammary tumor model.

Rapid 64Cu radiolabeling and in vivo evaluation of DSPE-NODAGA liposomes in a murine mammary tumor model.

Journal: Pharmacological research

Published: September 14, 2025

Design and Synthesis of a 18F-Radiolabeled Pyrrolo[2,3-d]pyrimidine Ligand as a CSF1R Receptor PET Imaging Agent.

Design and Synthesis of a 18F-Radiolabeled Pyrrolo[2,3-d]pyrimidine Ligand as a CSF1R Receptor PET Imaging Agent.

Journal: Journal of labelled compounds & radiopharmaceuticals

Published: September 10, 2024

In vitro and in vivo characterization of [64Cu][Cu(elesclomol)] as a novel theranostic agent for hypoxic solid tumors.

In vitro and in vivo characterization of [64Cu][Cu(elesclomol)] as a novel theranostic agent for hypoxic solid tumors.

Journal: European journal of nuclear medicine and molecular imaging

Published: January 25, 2023

Development of an automated production process of [64 Cu][Cu (ATSM)] for positron emission tomography imaging and theranostic applications.

Development of an automated production process of [64 Cu][Cu (ATSM)] for positron emission tomography imaging and theranostic applications.

Journal: Journal of labelled compounds & radiopharmaceuticals

Published: January 03, 2022

Hypoxia imaging and theranostic potential of [64Cu][Cu(ATSM)] and ionic Cu(II) salts: a review of current evidence and discussion of the retention mechanisms.

Hypoxia imaging and theranostic potential of [64Cu][Cu(ATSM)] and ionic Cu(II) salts: a review of current evidence and discussion of the retention mechanisms.

Journal: EJNMMI research

Published: December 25, 2019

Economical synthesis of 13C-labeled opiates, cocaine derivatives and selected urinary metabolites by derivatization of the natural products.

Economical synthesis of 13C-labeled opiates, cocaine derivatives and selected urinary metabolites by derivatization of the natural products.

Journal: Molecules (Basel, Switzerland)

Published: November 10, 2014

Synthesis of [13C4]-labeled ∆9-tetrahydrocannabinol and 11-nor-9-carboxy-∆9-tetrahydrocannabinol as internal standards for reducing ion suppressing/alteration effects in LC/MS-MS quantification.

Synthesis of [13C4]-labeled ∆9-tetrahydrocannabinol and 11-nor-9-carboxy-∆9-tetrahydrocannabinol as internal standards for reducing ion suppressing/alteration effects in LC/MS-MS quantification.

Journal: Molecules (Basel, Switzerland)

Published: July 30, 2014

Evaluation of ¹³C- and ²H-labeled internal standards for the determination of amphetamines in biological samples, by reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry.

Evaluation of ¹³C- and ²H-labeled internal standards for the determination of amphetamines in biological samples, by reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry.

Journal: Journal of chromatography. A

Published: January 13, 2014

Synthesis of [13C6]-labelled phenethylamine derivatives for drug quantification in biological samples.

Synthesis of [13C6]-labelled phenethylamine derivatives for drug quantification in biological samples.

Journal: Journal of labelled compounds & radiopharmaceuticals

Published: November 21, 2013

Showing 1-9 of 9

Last Updated: 09/26/2026